Target intelligence / Profile preview

B-cell receptor (BCR) specific for Neisseria meningitidis serogroup W-135 capsular polysaccharide (BCR (W-135 specific))

Target
BCR (W-135 specific)
Molecular classification
Receptor, Immunoglobulin
01

Overview

The B-cell receptor (BCR) specific for Neisseria meningitidis serogroup W-135 capsular polysaccharide is a specialized membrane-bound immunoglobulin found on the surface of B cells. It plays a pivotal role in the adaptive immune system by recognizing and binding to the unique capsular polysaccharide epitopes of the W-135 serogroup, which is characterized by a repeating sequence of galactose and sialic acid (PMID: 11553243). This interaction is the fundamental step in the efficacy of meningococcal conjugate vaccines, where the BCR-antigen binding triggers B-cell activation and the subsequent production of protective antibodies. These antibodies facilitate the clearance of the bacteria through complement-mediated lysis and opsonophagocytosis, thereby preventing invasive meningococcal disease (PMID: 22438871). As a therapeutic target in vaccinology, the BCR is engaged to establish immunological memory, ensuring a rapid and robust response upon subsequent exposure to the pathogen (Janeway's Immunobiology). Understanding the specificity of this receptor is crucial for the development of vaccines that provide broad and lasting protection against various meningococcal serogroups. The receptor's activation leads to the differentiation of B cells into long-lived plasma cells and memory B cells, which are essential for long-term immunity. In clinical practice, the success of targeting this receptor is measured by serum bactericidal activity, which correlates with protection against infection (FDA: Menveo Label).

Other names
Meningococcal serogroup W-135 specific B-cell receptorAnti-W-135 BCRNeisseria meningitidis serogroup W BCRW-135 polysaccharide-specific BCR
02

Mechanism of action

The vaccine antigen binds to the B-cell receptor, inducing receptor clustering and activation of downstream signaling cascades (e.g., via CD79A/B) that lead to B-cell differentiation into plasma cells and memory B cells (Janeway's Immunobiology; PMID: 22438871).

03

Biological functions

Immune responseAntigen recognitionB-cell activationAntibody production
04

Disease associations

InfectionMeningococcal meningitisMeningococcemia
05

Safety considerations

Injection site reactions (pain, redness, swelling)Systemic reactions (fever, headache, fatigue)Anaphylaxis (rare)Guillain-Barré syndrome (rarely reported) (FDA: Menactra Label)
06

Interacting drugs

Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra)

3 more in the full profile.

07

Biomarkers

Serum bactericidal activity (SBA) titers (PMID: 22438871)Serogroup W-135 specific IgG concentration (FDA: MenQuadfi Label)

Beyond the preview

Go deeper on B-cell receptor (BCR) specific for Neisseria meningitidis serogroup W-135 capsular polysaccharide (BCR (W-135 specific)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B-cell receptor (BCR) specific for Neisseria meningitidis serogroup W-135 capsular polysaccharide (BCR (W-135 specific)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call